PDCD10 and cerebrocostomandibular syndrome: A preclinical study showed that Ccm3 mice treated with anti-mouse BR3 to deplete B cells harbored smaller lesions, fewer mature CCMs [15], and decreased non-heme iron deposition, confirming the pathogenicity of the B-cell-mediated immune response in CCMs [15,22].